ESC Congress 2017

26 - 30 August 2017, Barcelona - Spain

Session Details

Late-Breaking Science in Heart Failure
Mon 28 Aug 08:30 - 10:00 Heart failure, other Late-Breaking Science Warsaw - Village 9
Chairpersons: Frank RUSCHITZKA (Zurich, Switzerland), Milton PACKER (Dallas, United States of America)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
08:302956Heart failure and death in new users of SGLT2 inhibitors vs other glucose-lowering drugs - consistent risk reduction across patient groups in 4 countries and >270,000 patients: The CVD-REAL StudyAnna NORHAMMAR (Stockholm, Sweden)
08:452957Efficacy of beta-blockers in heart failure according to left ventricular ejection fraction: An individual patient level analysis of double-blind randomised trialsDipak KOTECHA (Birmingham, United Kingdom)
09:002958Marked variation in the efficacy of beta-blockers across cardiovascular health: A Global systematic assessment of mortality, myocardial infarction and strokeOliver ZIFF (London, United Kingdom)
09:152959Heart Failure-Wii studyTiny JAARSMA (Norrkoping, Sweden)
09:302960Does the risk for heart failure (HF) modulate the effectiveness of empagliflozin on HF hospitalisation or CV death in patients with type 2 diabetes without HF? Insights from EMPA-REG OUTCOME Javed BUTLER (Atlanta, United States of America)
09:452961Predicting right heart failure after implantation of continuous flow left ventricular assist devices (EUROMACS-RHF) score: analysis of the EUROMACS dataOsama Ibrahim SOLIMAN (Rotterdam, Netherlands)